Patents by Inventor Stephen Baird

Stephen Baird has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LIGHT SENSING REAR-VIEW MIRROR ASSEMBLY
    Publication number: 20200172015
    Abstract: A light sensing rear-view mirror assembly for reducing glare during night driving includes a commercial vehicle. A pair of rear view mirrors is provided and each of the rear view mirrors is each mounted on a respective one of a driver's side and a passenger's side of the commercial vehicle. A pair of control circuits is each coupled to a respective one of the rear view mirrors. A pair of dimming units is each coupled to a respective one of the rear view mirrors. Each of the dimming units is electrically coupled to the control circuit on the respective rear view mirror. Moreover, each of the dimming units automatically reducing an intensity of light reflected in the respective rear view mirror wherein each of the dimming units is configured to enhance a driver's night vision.
    Type: Application
    Filed: December 4, 2018
    Publication date: June 4, 2020
    Inventor: Stephen Baird
  • Mammalian IAP gene family, primers, probes and detection methods
    Patent number: 7776552
    Abstract: Disclosed is substantially pure DNA encoding mammalian IAP polypeptides; and methods of using such DNA to express the IAP polypeptides in cells and animals to inhibit apoptosis. Also disclosed are conserved regions characteristic of the IAP family and primer and probes for the identification and isolation of additional IAP genes. In addition, methods for treating diseases and disorders involving apoptosis are provided.
    Type: Grant
    Filed: August 3, 2006
    Date of Patent: August 17, 2010
    Assignee: University of Ottawa
    Inventors: Robert G. Korneluk, Alexander E. MacKenzie, Stephen Baird, Peter Liston
  • DETECTION AND MODULATION OF IAPs AND NAIP FOR THE DIAGNOSIS AND TREATMENT OF PROLIFERATIVE DISEASE
    Publication number: 20090142334
    Abstract: Disclosed are diagnostic and prognostic kits for the detection and treatment of proliferative diseases such as ovarian cancer, breast cancer, and lymphoma. Also disclosed are cancer therapeutics utilizing IAP antisense nucleic acids, IAP fragments, and antibodies which specifically bind IAP polypeptides.
    Type: Application
    Filed: April 28, 2008
    Publication date: June 4, 2009
    Applicant: AEGERA THERPEUTICS, INC.
    Inventors: Robert G. Korneluk, Alexander E. Mackenzie, Peter Liston, Stephen Baird, Benjamin K. Tsang, Christine Pratt
  • Antisense IAP oligonucleotides and uses thereof
    Patent number: 7294713
    Abstract: The present invention feature antisense IAP oligonucleotides and other negative regulators of the IAP anti-apoptotic pathway, and methods for using them to enhance apoptosis.
    Type: Grant
    Filed: August 7, 2003
    Date of Patent: November 13, 2007
    Assignee: Aegera Therapeutics Inc.
    Inventors: Robert G. Korneluk, Eric LaCasse, Stephen Baird, Martin Holcik, Sean Young
  • Detection and modulation of IAPs and NAIP for the diagnosis and treatment of proliferative disease
    Publication number: 20070219360
    Abstract: Disclosed are diagnostic and prognostic kits for the detection and treatment of proliferative diseases such as ovarian cancer, breast cancer, and lymphoma. Also disclosed are cancer therapeutics utilizing IAP antisense nucleic acids, IAP fragments, and antibodies which specifically bind IAP polypeptides.
    Type: Application
    Filed: August 25, 2006
    Publication date: September 20, 2007
    Inventors: Robert G. Korneluk, Alexander E. MacKenzie, Peter Liston, Stephen Baird, Benjamin K. Tsang, Christine Pratt
  • Detection and modulation of IAPs and NAIP for the diagnosis and treatment of proliferative disease
    Publication number: 20070203088
    Abstract: Disclosed are diagnostic and prognostic kits for the detection and treatment of proliferative diseases such as ovarian cancer, breast cancer, and lymphoma. Also disclosed are cancer therapeutics utilizing IAP antisense nucleic acids, IAP fragments, and antibodies which specifically bind IAP polypeptides.
    Type: Application
    Filed: August 25, 2006
    Publication date: August 30, 2007
    Inventors: Robert Korneluk, Alexander MacKenzie, Peter Liston, Stephen Baird, Benjamin Tsang, Christine Pratt
  • Antisense IAP oligonucleotides and uses thereof
    Publication number: 20070142316
    Abstract: The present invention features antisense IAP oligonucleotides and other negative regulators of the IAP anti-apoptotic pathway, and methods for using them to enhance apoptosis.
    Type: Application
    Filed: December 18, 2006
    Publication date: June 21, 2007
    Inventors: Robert Korneluk, Eric LaCasse, Stephen Baird, Martin Holcik, Sean Young
  • Antisense IAP oligonucleotides and uses thereof
    Publication number: 20070123481
    Abstract: The present invention features antisense IAP oligonucleotides and other negative regulators of the IAP anti-apoptotic pathway, and methods for using them to enhance apoptosis.
    Type: Application
    Filed: June 30, 2006
    Publication date: May 31, 2007
    Inventors: Robert Korneluk, Eric LaCasse, Stephen Baird, Martin Holcik, Sean Young
  • Mammalian IAP gene family, primers, probes and detection methods
    Publication number: 20070066524
    Abstract: Disclosed is substantially pure DNA encoding mammalian IAP polypeptides; and methods of using such DNA to express the IAP polypeptides in cells and animals to inhibit apoptosis. Also disclosed are conserved regions characteristic of the IAP family and primer and probes for the identification and isolation of additional IAP genes. In addition, methods for treating diseases and disorders involving apoptosis are provided.
    Type: Application
    Filed: August 4, 2006
    Publication date: March 22, 2007
    Inventors: Robert Korneluk, Alexander MacKenzie, Stephen Baird, Peter Liston
  • Mammalian IAP gene family, primers, probes and detection methods
    Publication number: 20070048772
    Abstract: Disclosed is substantially pure DNA encoding mammalian IAP polypeptides; and methods of using such DNA to express the IAP polypeptides in cells and animals to inhibit apoptosis. Also disclosed are conserved regions characteristic of the IAP family and primer and probes for the identification and isolation of additional IAP genes. In addition, methods for treating diseases and disorders involving apoptosis are provided.
    Type: Application
    Filed: July 26, 2006
    Publication date: March 1, 2007
    Inventors: Robert Korneluk, Alexander MacKenzie, Stephen Baird, Peter Liston
  • Mammalian IAP gene family, primers, probes and detection methods
    Publication number: 20070042446
    Abstract: Disclosed is substantially pure DNA encoding mammalian IAP polypeptides; and methods of using such DNA to express the IAP polypeptides in cells and animals to inhibit apoptosis. Also disclosed are conserved regions characteristic of the IAP family and primer and probes for the identification and isolation of additional IAP genes. In addition, methods for treating diseases and disorders involving apoptosis are provided.
    Type: Application
    Filed: August 3, 2006
    Publication date: February 22, 2007
    Inventors: Robert Korneluk, Alexander MacKenzie, Stephen Baird, Peter Liston
  • Mammalian IAP gene family, primers, probes and detection methods
    Publication number: 20070031904
    Abstract: Disclosed is substantially pure DNA encoding mammalian IAP polypeptides; and methods of using such DNA to express the IAP polypeptides in cells and animals to inhibit apoptosis. Also disclosed are conserved regions characteristic of the IAP family and primer and probes for the identification and isolation of additional IAP genes. In addition, methods for treating diseases and disorders involving apoptosis are provided.
    Type: Application
    Filed: July 25, 2006
    Publication date: February 8, 2007
    Inventors: Robert Korneluk, Alexander MacKenzie, Stephen Baird, Peter Liston
  • Mammalian IAP gene family, primers, probes and detection methods
    Publication number: 20070031903
    Abstract: Disclosed is substantially pure DNA encoding mammalian IAP polypeptides; and methods of using such DNA to express the IAP polypeptides in cells and animals to inhibit apoptosis. Also disclosed are conserved regions characteristic of the IAP family and primer and probes for the identification and isolation of additional IAP genes. In addition, methods for treating diseases and disorders involving apoptosis are provided.
    Type: Application
    Filed: July 25, 2006
    Publication date: February 8, 2007
    Inventors: Robert Korneluk, Alexander MacKenzie, Stephen Baird, Peter Liston
  • Mammalian IAP gene family, primers, probes and detection methods
    Publication number: 20070026494
    Abstract: Disclosed is substantially pure DNA encoding mammalian IAP polypeptides; and methods of using such DNA to express the IAP polypeptides in cells and animals to inhibit apoptosis. Also disclosed are conserved regions characteristic of the IAP family and primer and probes for the identification and isolation of additional IAP genes. In addition, methods for treating diseases and disorders involving apoptosis are provided.
    Type: Application
    Filed: July 26, 2006
    Publication date: February 1, 2007
    Inventors: Robert Korneluk, Alexander MacKenzie, Stephen Baird, Peter Liston
  • Mammalian IAP gene family, primers, probes and detection methods
    Publication number: 20070027304
    Abstract: Disclosed is substantially pure DNA encoding mammalian IAP polypeptides; and methods of using such DNA to express the IAP polypeptides in cells and animals to inhibit apoptosis. Also disclosed are conserved regions characteristic of the IAP family and primer and probes for the identification and isolation of additional IAP genes. In addition, methods for treating diseases and disorders involving apoptosis are provided.
    Type: Application
    Filed: July 26, 2006
    Publication date: February 1, 2007
    Inventors: Robert Korneluk, Alexander MacKenzie, Stephen Baird, Peter Liston
  • Mammalian IAP gene family, primers, probes and detection methods
    Publication number: 20070026470
    Abstract: Disclosed is substantially pure DNA encoding mammalian IAP polypeptides; and methods of using such DNA to express the IAP polypeptides in cells and animals to inhibit apoptosis. Also disclosed are conserved regions characteristic of the IAP family and primer and probes for the identification and isolation of additional IAP genes. In addition, methods for treating diseases and disorders involving apoptosis are provided.
    Type: Application
    Filed: July 25, 2006
    Publication date: February 1, 2007
    Inventors: Robert Korneluk, Alexander MacKenzie, Stephen Baird, Peter Liston
  • Mammalian IAP gene family, primers, probes, and detection methods
    Publication number: 20070009971
    Abstract: Disclosed is substantially pure DNA encoding mammalian IAP polypeptides; substantially pure polypeptides; and methods of using such DNA to express the IAP polypeptides in cells and animals to inhibit apoptosis. Also disclosed are conserved regions characteristic of the IAP family and primers and probes for the identification and isolation of additional IAP genes. In addition, methods for treating diseases and disorders involving apoptosis are provided.
    Type: Application
    Filed: December 22, 2005
    Publication date: January 11, 2007
    Applicant: Aegera Therapeutics, Inc.
    Inventors: Robert Korneluk, Alexander MacKenzie, Stephen Baird, Peter Liston
  • Mammalian IAP gene family, primers, probes and detection methods
    Publication number: 20060205021
    Abstract: Disclosed is substantially pure DNA encoding mammalian IAP polypeptides; substantially pure polypeptides; and methods of using such DNA to express the IAP polypeptides in cells and animals to inhibit apoptosis. Also disclosed are conserved regions characteristic of the IAP family and primers and probes for the identification and isolation of additional IAP genes. In addition, methods for treating diseases and disorders involving apoptosis are provided.
    Type: Application
    Filed: January 19, 2006
    Publication date: September 14, 2006
    Applicant: Aegera Therapeutics, Inc.
    Inventors: Robert Korneluk, Alexander MacKenzie, Stephen Baird, Peter Liston
  • Detection and modulation of IAPS and NAIP for the diagnosis and treatment of proliferative disease
    Publication number: 20060189563
    Abstract: Disclosed are diagnostic and prognostic kits for the detection and treatment of proliferative diseases such as ovarian cancer, breast cancer, and lymphoma. Also disclosed are cancer therapeutics utilizing IAP antisense nucleic acids IAP fragments, and antibodies which specifically bind IAP polypeptides.
    Type: Application
    Filed: March 20, 2006
    Publication date: August 24, 2006
    Inventors: Robert Korneluk, Alexander MacKenzie, Peter Liston, Stephen Baird, Benjamin Tsang, Christine Pratt
  • Detection and modulation of IAPs and NAIP for the diagnosis and treatment of proliferative disease
    Patent number: 7087584
    Abstract: Disclosed are diagnostic and prognostic kits for the detection and treatment of proliferative diseases such as ovarian cancer, breast cancer, and lymphoma. Also disclosed are cancer therapeutics utilizing IAP antisense nucleic acids IAP fragments, and antibodies which specifically bind IAP polypeptides.
    Type: Grant
    Filed: October 9, 2001
    Date of Patent: August 8, 2006
    Assignee: Aegera Therapeutics Inc.
    Inventors: Robert G. Korneluk, Alexander E. Mackenzie, Peter Liston, Stephen Baird, Benjamin K. Tsang, Christine Pratt